• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泪小管炎的保留切口管理:手术治疗的有效替代方法

Incision-sparing management of canaliculitis: an efficacious alternative to surgical management.

作者信息

Law David Zhiwei, Goh E-Shawn

机构信息

Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; Vision Performance Centre, Military Medicine Institute, Singapore Armed Forces, Singapore.

Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; Eagle Eye Centre, Mount Elizabeth Novena Specialist Centre, Singapore.

出版信息

Can J Ophthalmol. 2017 Jun;52(3):258-263. doi: 10.1016/j.jcjo.2016.10.013. Epub 2017 Jan 10.

DOI:10.1016/j.jcjo.2016.10.013
PMID:28576205
Abstract

OBJECTIVE

The aim of this study was to describe the outcomes of conservative (punctal dilation, manual expression, microcurettage, and canalicular irrigation with antibiotics) and surgical (punctoplasty) modalities for the management of canaliculitis in an Asian population.

METHODS

The medical records of 11 consecutive patients (12 eyes) presenting with canaliculitis to one surgeon from August 2010 to January 2014 were reviewed. The clinical presentation, findings, management, microbiology, and treatment outcomes were studied.

RESULTS

The mean age was 70.6 years (57-91 years), 8 (72.7%) patients were females, and all 11(100%) were Chinese. The majority had unilateral canaliculitis-8 (66.7%) right eye only and 4 (33.3%) left eye only (1 patient had consecutive right canaliculitis followed by left canaliculitis)-involving the lower canaliculi (75%). Ten (83.3%) eyes had primary canaliculitis, and 2 (16.7%) eyes had secondary canaliculitis from punctal plug insertion. Common presenting symptoms included eye discharge (75%) and eyelid swelling/redness (50%). Common clinical signs included mucopurulent punctal regurgitation (75%) and pouting punctum (58.3%). Facultative anaerobes (56.3%) formed the majority of organisms, and the most common bacteria isolated were Streptococcus spp. (18.8%). Mean duration to definitive treatment was 35 days (0-126 days). Ten (83.3%) eyes were successfully treated with incision-sparing modalities, and 2 (16.7%) eyes were treated surgically. No recurrences were observed at 3, 6, and 12 months, and only 1 (10.0%) of the 10 conservatively managed eyes had a recurrence of canaliculitis after 3.8 years.

CONCLUSIONS

Surgical modalities remain effective for the treatment of canaliculitis. However, they are not without disadvantages, such as scarring, discomfort, infection, and recurrence of punctal stenosis. In our experience, incision-sparing modalities are effective in the treatment of canaliculitis and have low recurrence rates.

摘要

目的

本研究旨在描述在亚洲人群中采用保守治疗(泪点扩张、手工挤压、微刮除以及用抗生素进行泪小管冲洗)和手术治疗(泪点成形术)方式管理泪小管炎的结果。

方法

回顾了2010年8月至2014年1月期间同一位外科医生连续收治的11例(12只眼)泪小管炎患者的病历。研究了临床表现、检查结果、治疗方法、微生物学以及治疗结果。

结果

平均年龄为70.6岁(57 - 91岁),8例(72.7%)患者为女性,所有11例(100%)均为中国人。大多数患者为单侧泪小管炎——8例(66.7%)仅累及右眼,4例(33.3%)仅累及左眼(1例患者先后出现右眼和左眼泪小管炎),累及下泪小管的占75%。10只眼(83.3%)为原发性泪小管炎,2只眼(16.7%)为泪点栓植入后继发性泪小管炎。常见的症状包括眼部分泌物(75%)和眼睑肿胀/发红(50%)。常见的临床体征包括黏液脓性泪点反流(75%)和泪点外翻(58.3%)。兼性厌氧菌占微生物的大多数(56.3%),分离出的最常见细菌为链球菌属(18.8%)。明确治疗的平均时长为35天(0 - 126天)。10只眼(83.3%)通过保留切口的方式成功治愈,2只眼(16.7%)接受了手术治疗。在3个月、6个月和12个月时均未观察到复发情况,在10只接受保守治疗的眼中,只有1只眼(10.0%)在3.8年后出现了泪小管炎复发。

结论

手术治疗方式对泪小管炎的治疗仍然有效。然而,它们并非没有缺点,如瘢痕形成、不适、感染以及泪点狭窄复发。根据我们的经验,保留切口的方式在治疗泪小管炎方面有效且复发率低。

相似文献

1
Incision-sparing management of canaliculitis: an efficacious alternative to surgical management.泪小管炎的保留切口管理:手术治疗的有效替代方法
Can J Ophthalmol. 2017 Jun;52(3):258-263. doi: 10.1016/j.jcjo.2016.10.013. Epub 2017 Jan 10.
2
Primary canaliculitis: clinical features, microbiological profile, and management outcome.原发性泪小管炎:临床特征、微生物谱和治疗结果。
Ophthalmic Plast Reconstr Surg. 2012 Sep-Oct;28(5):355-60. doi: 10.1097/IOP.0b013e31825fb0cd.
3
Punctal dilatation and non-incisional canalicular curettage in the management of infectious canaliculitis.泪小点扩张联合非切口泪小管刮除术治疗感染性泪囊炎。
Orbit. 2020 Dec;39(6):408-412. doi: 10.1080/01676830.2019.1704797. Epub 2020 Jan 3.
4
Clinical characteristics, treatment patterns, and outcomes of primary canaliculitis among patients in Beijing, China.中国北京原发性泪小管炎患者的临床特征、治疗模式及预后
Biomed Res Int. 2015;2015:904756. doi: 10.1155/2015/904756. Epub 2015 Feb 17.
5
Clinical features, microbiological profiles and treatment outcome of lacrimal plug-related canaliculitis compared with those of primary canaliculitis.泪点栓相关泪小管炎与原发性泪小管炎的临床特征、微生物学特征及治疗结果比较
Br J Ophthalmol. 2016 Sep;100(9):1285-9. doi: 10.1136/bjophthalmol-2015-307500. Epub 2015 Dec 23.
6
Lacrimal Canaliculitis: A Major Review.泪小管炎:一项重要综述。
Semin Ophthalmol. 2024 Nov;39(8):586-594. doi: 10.1080/08820538.2024.2354689. Epub 2024 May 19.
7
Management of complications after insertion of the SmartPlug punctal plug: a study of 28 patients.SmartPlug泪点塞植入术后并发症的处理:28例患者的研究
Ophthalmology. 2006 Oct;113(10):1859.e1-6. doi: 10.1016/j.ophtha.2006.05.032. Epub 2006 Aug 22.
8
Primary canaliculitis.原发性泪小管炎。
Ophthalmic Plast Reconstr Surg. 2009 Nov-Dec;25(6):481-4. doi: 10.1097/IOP.0b013e3181b8c185.
9
Clinical Treatment Efficacy Using One-snip Punctoplasty and Irrigation Technique in Primary Canaliculitis Patients.单剪式泪点成形术联合冲洗技术治疗原发性泪小管炎的临床疗效
Korean J Ophthalmol. 2022 Apr;36(2):154-158. doi: 10.3341/kjo.2022.0009. Epub 2022 Feb 18.
10
Punctum-sparing canaliculotomy for the treatment of canaliculitis.经皮泪小管切开术治疗泪小管炎。
Ophthalmic Plast Reconstr Surg. 2012 Jan-Feb;28(1):63-5. doi: 10.1097/IOP.0b013e318244a367.

引用本文的文献

1
A case report on complete cure of recurrent primary canaliculitis by 4-snip punctoplasty and canalicular curettage.一例经四点切开成形术及泪小管刮除术治愈复发性原发性泪小管炎的病例报告。
Medicine (Baltimore). 2018 Dec;97(49):e13508. doi: 10.1097/MD.0000000000013508.